| Year |
Citation |
Score |
| 2012 |
Cardiel AC, Benson MC, Bishop LM, Louis KM, Yeager JC, Tan Y, Hamers RJ. Chemically directed assembly of photoactive metal oxide nanoparticle heterojunctions via the copper-catalyzed azide-alkyne cycloaddition "click" reaction. Acs Nano. 6: 310-8. PMID 22196212 DOI: 10.1021/Nn203585R |
0.679 |
|
| 2012 |
Bishop LM, Yeager JC, Chen X, Wheeler JN, Torelli MD, Benson MC, Burke SD, Pedersen JA, Hamers RJ. A citric acid-derived ligand for modular functionalization of metal oxide surfaces via "click" chemistry. Langmuir : the Acs Journal of Surfaces and Colloids. 28: 1322-9. PMID 22145802 DOI: 10.1021/La204145T |
0.673 |
|
| 2012 |
Shah S, Benson MC, Bishop LM, Huhn AM, Ruther RE, Yeager JC, Tan Y, Louis KM, Hamers RJ. Chemically assembled heterojunctions of SnO 2 nanorods with TiO 2 nanoparticles via "click" chemistry Journal of Materials Chemistry. 22: 11561-11567. DOI: 10.1039/C2Jm31227A |
0.618 |
|
| 2011 |
Benson MC, Ruther RE, Gerken JB, Rigsby ML, Bishop LM, Tan Y, Stahl SS, Hamers RJ. Modular "click" chemistry for electrochemically and photoelectrochemically active molecular interfaces to tin oxide surfaces. Acs Applied Materials & Interfaces. 3: 3110-9. PMID 21766849 DOI: 10.1021/Am200615R |
0.753 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2011 |
McKiernan JM, Barlow LJ, Laudano MA, Mann MJ, Petrylak DP, Benson MC. A phase I trial of intravesical nanoparticle albumin-bound paclitaxel in the treatment of bacillus Calmette-Guérin refractory nonmuscle invasive bladder cancer. The Journal of Urology. 186: 448-51. PMID 21680003 DOI: 10.1016/j.juro.2011.03.129 |
0.276 |
|
| 2014 |
McKiernan JM, Holder DD, Ghandour RA, Barlow LJ, Ahn JJ, Kates M, Badalato GM, Roychoudhury A, Decastro GJ, Benson MC. Phase II trial of intravesical nanoparticle albumin bound paclitaxel for the treatment of nonmuscle invasive urothelial carcinoma of the bladder after bacillus Calmette-Guérin treatment failure. The Journal of Urology. 192: 1633-8. PMID 24996128 DOI: 10.1016/J.Juro.2014.06.084 |
0.161 |
|
| 2003 |
Anastasiadis AG, Benson MC, Rosenwasser MP, Salomon L, El-Rashidy H, Ghafar MA, McKiernan JM, Burchardt M, Shabsigh R. Cavernous nerve graft reconstruction during radical prostatectomy or radical cystectomy: Safe and technically feasible Prostate Cancer and Prostatic Diseases. 6: 56-60. PMID 12664067 DOI: 10.1038/sj.pcan.4500613 |
0.104 |
|
| 1996 |
Katz AE, De Vries GM, Benson MC, Buttyan RE, O'Toole K, Rubin MA, Stifelman M, Olsson CA. The role of the reverse-transcriptase polymerase chain reaction assay for prostate-specific antigen in the selection of patients for radical prostatectomy Urologic Clinics of North America. 23: 541-549. PMID 8948409 DOI: 10.1016/S0094-0143(05)70334-7 |
0.09 |
|
| 2004 |
Petrylak DP, Tangen CM, Hussain MHA, Lara PN, Jones JA, Taplin ME, Burch PA, Berry D, Moinpour C, Kohli M, Benson MC, Small EJ, Raghavan D, Crawford ED. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer New England Journal of Medicine. 351: 1513-1520. PMID 15470214 DOI: 10.1056/NEJMoa041318 |
0.079 |
|
| 1997 |
Rubin MA, Fang M, Stifelman MD, De Vries GM, Buttyan R, Benson MC, Katz AE, Olsson CA, O'Toole K. Enhanced Reverse Transcriptase Polymerase Chain Reaction for Prostate-specific Antigen Combined with Needle Biopsy Results: A Superior Predictor of pT3 Disease Molecular Diagnosis. 2: 135-145. |
0.071 |
|
| 1997 |
Goluboff ET, Heitjan DF, DeVries GM, Katz AE, Benson MC, Olsson CA. Pretreatment prostate specific antigen doubling times: Use in patients before radical prostatectomy Journal of Urology. 158: 1876-1879. PMID 9334621 DOI: 10.1016/S0022-5347(01)64154-5 |
0.069 |
|
| 2009 |
Capodice JL, Gorroochurn P, Cammack AS, Eric G, McKiernan JM, Benson MC, Stone BA, Katz AE. Zyflamend in men with high-grade prostatic intraepithelial neoplasia: results of a phase I clinical trial. Journal of the Society For Integrative Oncology. 7: 43-51. PMID 19476738 DOI: 10.2310/7200.2009.0012 |
0.069 |
|
| 2000 |
Burchardt M, Burchardt T, Shabsigh A, De La Taille A, Benson MC, Sawczuk I. Current concepts in biomarker technology for bladder cancers Clinical Chemistry. 46: 595-605. PMID 10794739 |
0.066 |
|
| 2004 |
Lam JS, Sclar JD, Desai M, Mansukhani MM, Benson MC, Goluboff ET. Is hispanic race an important predictor of treatment failure following radical prostatectomy for prostate cancer? Journal of Urology. 172: 1856-1859. PMID 15540738 DOI: 10.1097/01.ju.0000141783.67470.55 |
0.065 |
|
| 1999 |
De La Taille A, Olsson CA, Buttyan R, Benson MC, Bagiella E, Cao Y, Burchardt M, Chopin DK, Katz AE. Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: Long term follow-up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomy International Journal of Cancer. 84: 360-364. PMID 10404086 DOI: 10.1002/(Sici)1097-0215(19990820)84:4<360::Aid-Ijc5>3.0.Co;2-E |
0.064 |
|
| 2014 |
Chua CW, Shibata M, Lei M, Toivanen R, Barlow LJ, Bergren SK, Badani KK, McKiernan JM, Benson MC, Hibshoosh H, Shen MM. Single luminal epithelial progenitors can generate prostate organoids in culture. Nature Cell Biology. 16: 951-61, 1-4. PMID 25241035 DOI: 10.1038/ncb3047 |
0.063 |
|
| 2004 |
Goetzl MA, Desai M, Mansukhani M, Goluboff ET, Katz AE, Sawczuk IS, Benson MC, Olsson CA, McKiernan JM. Natural history and clinical outcome of sporadic renal cortical tumors diagnosed in the young adult Urology. 63: 41-45. PMID 14751345 DOI: 10.1016/j.urology.2003.08.020 |
0.06 |
|
| 2003 |
Lam JS, Desai M, Mansukhani MM, Benson MC, Goluboff ET. Is hispanic race an independent risk factor for pathological stage in patients undergoing radical prostatectomy? Journal of Urology. 170: 2288-2291. PMID 14634398 DOI: 10.1097/01.ju.0000091101.31497.71 |
0.06 |
|
| 2003 |
Salomon L, Anastasiadis AG, Johnson CW, McKiernan JM, Goluboff ET, Abbou CC, Olsson CA, Benson MC. Seminal vesicle involvement after radical prostatectomy: Predicting risk factors for progression Urology. 62: 304-309. PMID 12893340 DOI: 10.1016/S0090-4295(03)00373-X |
0.058 |
|
| 2003 |
Ghafar MA, Anastasiadis AG, Chen MW, Burchardt M, Olsson LE, Xie H, Benson MC, Buttyan R. Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells Prostate. 54: 58-67. PMID 12481256 DOI: 10.1002/pros.10162 |
0.058 |
|
| 2004 |
McKiernan J, Benson MC. Predicting the clinical course of prostate cancer Journal of Clinical Investigation. 113: 806-808. PMID 15067311 DOI: 10.1172/JCI200421310 |
0.058 |
|
| 2007 |
Kibel AS, Rosenbaum E, Kattan MW, Picus J, Dreicer R, Klein EA, Chatta GS, Nelson JB, DiPaola RS, Roth BJ, Cookson MS, Wilding G, Jarrard DF, Beer TM, Ryan CW, ... ... Benson MC, et al. Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study. The Journal of Urology. 177: 1777-81. PMID 17437819 DOI: 10.1016/J.Juro.2007.01.028 |
0.057 |
|
| 1998 |
Benson MC. Reply to improvement of specificity in PSA-based screening by using PSA- transition zone density and percent free PSA in addition to total PSA levels Prostate. 37: 138-139. DOI: 10.1002/(SICI)1097-0045(19981101)37:3<138::AID-PROS2>3.0.CO;2-O |
0.056 |
|
| 2006 |
Mitchell RE, Desai M, Shah JB, Olsson CA, Benson MC, McKiernan JM. Preoperative serum prostate specific antigen remains a significant prognostic variable in predicting biochemical failure after radical prostatectomy. The Journal of Urology. 175: 1663-7; discussion 1. PMID 16600724 DOI: 10.1016/S0022-5347(05)01022-0 |
0.055 |
|
| 1998 |
Goluboff ET, Saidi JA, Mazer S, Bagiella E, Heitjan DF, Benson MC, Olsson CA. Urinary continence after radical prostatectomy: The Columbia experience Journal of Urology. 159: 1276-1280. PMID 9507852 DOI: 10.1016/S0022-5347(01)63580-8 |
0.054 |
|
| 1997 |
Ingenito AC, Ennis RD, Hsu IC, Begg MD, Benson MC, Schiff PB. Re-examining the role of prostate-specific antigen density in predicting outcome for clinically localized prostate cancer Urology. 50: 73-78. PMID 9218022 DOI: 10.1016/S0090-4295(97)00202-1 |
0.054 |
|
| 2007 |
Gjertson CK, Asher KP, Sclar JD, Goluboff ET, Olsson CA, Benson MC, McKiernan JM. Local control and long-term disease-free survival for stage D1 (T2-T4N1-N2M0) prostate cancer after radical prostatectomy in the PSA era. Urology. 70: 723-7. PMID 17991544 DOI: 10.1016/j.urology.2007.05.014 |
0.054 |
|
| 2014 |
Shapiro EY, Scarberry K, Patel T, Bergman A, Ahn JJ, Sahi N, RoyChoudhury A, Deutch I, McKiernan JM, Benson MC, Badani KK. Comparison of robot-assisted and open retropubic radical prostatectomy for risk of biochemical progression in men with positive surgical margins. Journal of Endourology / Endourological Society. 28: 208-13. PMID 24044423 DOI: 10.1089/end.2013.0393 |
0.053 |
|
| 2011 |
Korets R, Mues AC, Graversen JA, Gupta M, Benson MC, Cooper KL, Landman J, Badani KK. Validating the use of the Mimic dV-trainer for robotic surgery skill acquisition among urology residents. Urology. 78: 1326-30. PMID 22001096 DOI: 10.1016/J.Urology.2011.07.1426 |
0.052 |
|
| 2002 |
Gilbert SM, Benson MC, McKiernan JM. Linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in the African-American population Current Urology Reports. 3: 189-193. PMID 12084187 DOI: 10.1007/S11934-002-0063-Y |
0.051 |
|
| 1999 |
Benson MC, Olsson CA. Continent urinary diversion Urologic Clinics of North America. 26: 125-147. PMID 10086055 |
0.05 |
|
| 2000 |
Lee N, Fawaaz R, Olsson CA, Benson MC, Petrylak DP, Schiff PB, Bagiella E, Singh A, Ennis RD. Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients International Journal of Radiation Oncology Biology Physics. 48: 1443-1446. PMID 11121646 DOI: 10.1016/S0360-3016(00)00785-9 |
0.049 |
|
| 2007 |
Pierorazio PM, Spencer BA, McCann TR, McKiernan JM, Benson MC. Preoperative risk stratification predicts likelihood of concurrent PSA-free survival, continence, and potency (the trifecta analysis) after radical retropubic prostatectomy. Urology. 70: 717-22. PMID 17991543 DOI: 10.1016/j.urology.2007.06.639 |
0.049 |
|
| 2015 |
Pagano MJ, Whalen MJ, Paulucci DJ, Reddy BN, Matulay JT, Rothberg M, Scarberry K, Patel T, Shapiro EY, RoyChoudhury A, McKiernan J, Benson MC, Badani KK. Predictors of biochemical recurrence in pT3b prostate cancer after radical prostatectomy without adjuvant radiotherapy. The Prostate. PMID 26481325 DOI: 10.1002/Pros.23114 |
0.048 |
|
| 2003 |
Lam JS, Cheung YK, Benson MC, Goluboff ET. Comparison of the predictive accuracy of serum prostate specific antigen levels and prostate specific antigen density in the detection of prostate cancer in Hispanic-American and white men Journal of Urology. 170: 451-456. PMID 12853797 |
0.048 |
|
| 1998 |
De la Taille A, Buttyan R, Benson MC, Katz AE. The role of tumor biomarkers as predictors of serum PSA recurrence after radical prostatectomy Seminars in Urologic Oncology. 16: 137-144. PMID 9741418 |
0.048 |
|
| 2000 |
Nejat RJ, Rashid HH, Bagiella E, Katz AE, Benson MC. A prospective analysis of time to normalization of serum testosterone after withdrawal of androgen deprivation therapy Journal of Urology. 164: 1891-1894. PMID 11061874 DOI: 10.1016/S0022-5347(05)66910-8 |
0.048 |
|
| 2012 |
Domingo-Domenech J, Vidal SJ, Rodriguez-Bravo V, Castillo-Martin M, Quinn SA, Rodriguez-Barrueco R, Bonal DM, Charytonowicz E, Gladoun N, de la Iglesia-Vicente J, Petrylak DP, Benson MC, Silva JM, Cordon-Cardo C. Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells. Cancer Cell. 22: 373-88. PMID 22975379 DOI: 10.1016/J.Ccr.2012.07.016 |
0.048 |
|
| 2007 |
Pierorazio PM, Lambert SM, Matsukhani M, Sprenkle PC, McCann TR, Katz AE, Olsson CA, Benson MC, McKiernan JM. High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy. Bju International. 100: 1066-70. PMID 17784880 DOI: 10.1111/j.1464-410X.2007.07115.x |
0.047 |
|
| 2002 |
Mosbacher MR, Schiff PB, O'Toole KM, Benson MC, Olsson CA, Brody RA, Ennis RD. Postprostatectomy salvage radiation therapy for prostate cancer: Impact of pathological and biochemical variables and prostate fossa biopsy Cancer Journal. 8: 242-246. PMID 12074323 DOI: 10.1097/00130404-200205000-00007 |
0.046 |
|
| 2009 |
Liu T, Mansukhani MM, Benson MC, Ennis R, Yoshida E, Schiff PB, Zhang P, Zhou J, Kutcher GJ. A feasibility study of novel ultrasonic tissue characterization for prostate-cancer diagnosis: 2D spectrum analysis of in vivo data with histology as gold standard. Medical Physics. 36: 3504-11. PMID 19746784 DOI: 10.1118/1.3166360 |
0.046 |
|
| 2011 |
Truesdale MD, Cheetham PJ, Turk AT, Sartori S, Hruby GW, Dinneen EP, Benson MC, Badani KK. Gleason score concordance on biopsy-confirmed prostate cancer: is pathological re-evaluation necessary prior to radical prostatectomy? Bju International. 107: 749-54. PMID 20840549 DOI: 10.1111/j.1464-410X.2010.09570.x |
0.046 |
|
| 2004 |
Johnson CW, McKiernan JM, Anastasiadis AG, Salomon L, Eaton S, Goluboff ET, Olsson CA, Benson MC. Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesicles Urologic Oncology: Seminars and Original Investigations. 22: 107-111. PMID 15082006 DOI: 10.1016/S1078-1439(03)00138-8 |
0.045 |
|
| 2003 |
Gilbert SM, Veltri RW, Sawczuk A, Shabsigh A, Knowles DR, Bright S, O'Dowd GJ, Olsson CA, Benson MC, Sawczuk IS. Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer Urology. 61: 539-543. PMID 12639642 DOI: 10.1016/S0090-4295(02)02400-7 |
0.045 |
|
| 2003 |
Gewanter RM, Katz AE, Olsson CA, Benson MC, Singh A, Schiff PB, Ennis RD. RT-PCR for PSA as a prognostic factor for patients with clinically localized prostate cancer treated with radiotherapy Urology. 61: 967-971. PMID 12736017 DOI: 10.1016/S0090-4295(02)02581-5 |
0.045 |
|
| 2013 |
Ritch CR, Morrison BF, Hruby G, Coard KC, Mayhew R, Aiken W, Benson MC, McKiernan JM. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison. Bju International. 111: E186-90. PMID 23107067 DOI: 10.1111/j.1464-410X.2012.11540.x |
0.044 |
|
| 2006 |
Yang X, Chen MW, Terry S, Vacherot F, Bemis DL, Capodice J, Kitajewski J, de la Taille A, Benson MC, Guo Y, Buttyan R. Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells. Oncogene. 25: 3436-44. PMID 16474850 DOI: 10.1038/Sj.Onc.1209366 |
0.044 |
|
| 2013 |
Wambi CO, Patel T, Shapiro EY, Tal O, Hruby GW, Berg WT, Benson MC, Badani KK. Findings of routine apical margin biopsy during robot-assisted radical prostatectomy. Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A. 23: 511-5. PMID 23621833 DOI: 10.1089/lap.2012.0417 |
0.044 |
|
| 2008 |
Gonzalez JR, Laudano MA, McCann TR, McKiernan JM, Benson MC. A review of high-risk prostate cancer and the role of neo-adjuvant and adjuvant therapies. World Journal of Urology. 26: 475-80. PMID 18762948 DOI: 10.1007/s00345-008-0314-8 |
0.044 |
|
| 2005 |
Yang X, Chen MW, Terry S, Vacherot F, Chopin DK, Bemis DL, Kitajewski J, Benson MC, Guo Y, Buttyan R. A human- and male-specific protocadherin that acts through the wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells. Cancer Research. 65: 5263-71. PMID 15958572 DOI: 10.1158/0008-5472.Can-05-0162 |
0.043 |
|
| 2000 |
De La Taille A, Hayek O, Benson MC, Bagiella E, Olsson CA, Fatal M, Katz AE. Salvage cryotherapy for recurrent prostate cancer after radiation therapy: The Columbia experience Urology. 55: 79-84. PMID 10654899 DOI: 10.1016/S0090-4295(99)00390-8 |
0.043 |
|
| 2005 |
Shah JB, Reese AC, McKiernan JM, Benson MC. PSA updated: Still relevant in the new millennium? European Urology. 47: 427-432. PMID 15774237 DOI: 10.1016/j.eururo.2004.12.020 |
0.043 |
|
| 2015 |
Lascano D, Pak JS, Kates M, Finkelstein JB, Silva M, Hagen E, RoyChoudhury A, Bivalacqua TJ, DeCastro GJ, Benson MC, McKiernan JM. Validation of a frailty index in patients undergoing curative surgery for urologic malignancy and comparison with other risk stratification tools. Urologic Oncology. PMID 26163940 DOI: 10.1016/J.Urolonc.2015.06.002 |
0.043 |
|
| 2009 |
Laudano MA, Badani KK, McCann TR, Mann MJ, Ritch C, Desai M, Benson MC, McKiernan JM. Significant change in predicted risk of biochemical recurrence after radical prostatectomy more common in black than in white men. Urology. 74: 660-4. PMID 19589568 DOI: 10.1016/j.urology.2008.10.075 |
0.043 |
|
| 2011 |
Truesdale MD, Polland AR, Graversen JA, Sartori S, Hruby GW, Landman J, McKiernan JM, Benson MC, Badani KK. Impact of HMG-CoA reductase inhibitor (statin) use on blood loss during robot-assisted and open radical prostatectomy. Journal of Endourology / Endourological Society. 25: 1427-33. PMID 21797762 DOI: 10.1089/end.2010.0688 |
0.042 |
|
| 2013 |
Irshad S, Bansal M, Castillo-Martin M, Zheng T, Aytes A, Wenske S, Le Magnen C, Guarnieri P, Sumazin P, Benson MC, Shen MM, Califano A, Abate-Shen C. A molecular signature predictive of indolent prostate cancer. Science Translational Medicine. 5: 202ra122. PMID 24027026 DOI: 10.1126/Scitranslmed.3006408 |
0.042 |
|
| 2012 |
Shapiro EY, Lipsky MJ, Cha DY, McKiernan JM, Benson MC, Gupta M. Outcomes of intrarenal Bacillus Calmette-Guérin/interferon-α2B for biopsy-proven upper-tract carcinoma in situ. Journal of Endourology / Endourological Society. 26: 1645-50. PMID 22834939 DOI: 10.1089/end.2012.0229 |
0.042 |
|
| 2016 |
Haas CR, Barlow LJ, Badalato GM, DeCastro GJ, Benson MC, McKiernan JM. The Timing of Radical Cystectomy for BCG Failure: Comparison of Outcomes and Risk Factors for Prognosis. The Journal of Urology. PMID 26807928 DOI: 10.1016/j.juro.2016.01.087 |
0.041 |
|
| 2001 |
Ghafar MA, Johnson CW, De La Taille A, Benson MC, Bagiella E, Fatal M, Olsson CA, Katz AE. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: The Columbia experience Journal of Urology. 166: 1333-1337. PMID 11547068 DOI: 10.1016/S0022-5347(05)65763-1 |
0.041 |
|
| 2013 |
Wenske S, Olsson CA, Benson MC. Outcomes of distal ureteral reconstruction through reimplantation with psoas hitch, Boari flap, or ureteroneocystostomy for benign or malignant ureteral obstruction or injury. Urology. 82: 231-6. PMID 23642933 DOI: 10.1016/j.urology.2013.02.046 |
0.041 |
|
| 2006 |
Shah JN, Wuu CS, Katz AE, Laguna JL, Benson MC, Ennis RD. Improved biochemical control and clinical disease-free survival with intraoperative versus preoperative preplanning for transperineal interstitial permanent prostate brachytherapy. Cancer Journal (Sudbury, Mass.). 12: 289-97. PMID 16925973 DOI: 10.1097/00130404-200607000-00007 |
0.041 |
|
| 2003 |
Lam JS, Benson MC, O'Donnell MA, Sawczuk A, Gavazzi A, Wechsler MH, Sawczuk IS. Bacillus Calmete-Guérin plus interferon-α2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity Urologic Oncology: Seminars and Original Investigations. 21: 354-360. PMID 14670544 DOI: 10.1016/S1078-1439(03)00012-7 |
0.041 |
|
| 2003 |
Gilbert SM, Olsson CA, Benson MC, McKiernan JM. The role of intravenous zoledronic acid in the management of high-risk prostate cancer Current Opinion in Urology. 13: 133-135. PMID 12584473 DOI: 10.1097/00042307-200303000-00008 |
0.04 |
|
| 2007 |
Heymann JJ, Benson MC, O'Toole KM, Malyszko B, Brody R, Vecchio D, Schiff PB, Mansukhani MM, Ennis RD. Phase II study of neoadjuvant androgen deprivation followed by external-beam radiotherapy with 9 months of androgen deprivation for intermediate- to high-risk localized prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 77-84. PMID 17194907 DOI: 10.1200/JCO.2005.05.0419 |
0.04 |
|
| 2000 |
Ennis RD, Petrylak DP, Singh P, Bagiella E, O'Toole KM, Benson MC, Olsson CA. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer Journal of Urology. 163: 1413-1418. PMID 10751847 DOI: 10.1016/S0022-5347(05)67632-X |
0.04 |
|
| 2016 |
Motamedinia P, Scott AN, Bate KL, Sadeghi N, Salazar G, Shapiro E, Ahn J, Lipsky M, Lin J, Hruby GW, Badani KK, Petrylak DP, Benson MC, Donovan MJ, Comper WD, et al. Urine Exosomes for Non-Invasive Assessment of Gene Expression and Mutations of Prostate Cancer. Plos One. 11: e0154507. PMID 27144529 DOI: 10.1371/journal.pone.0154507 |
0.039 |
|
| 1999 |
Brawer MK, Benson MC, Bostwick DG, Djavan B, Lilja H, Semjonow A, Su S, Zhou Z. Prostate-specific antigen and other serum markers: Current concepts from the world health organization second international consultation on prostate cancer Seminars in Urologic Oncology. 17: 206-221. PMID 10632122 |
0.039 |
|
| 2008 |
DeCastro GJ, McCann T, Benson MC, McKiernan JM. Pathologic T2 stage subgroups and recurrence-free survival after radical prostatectomy. Urology. 72: 1214-8. PMID 18597825 DOI: 10.1016/j.urology.2008.01.054 |
0.039 |
|
| 2015 |
Danzig MR, Kotamarti S, Ghandour RA, Rothberg MB, Dubow BP, Benson MC, Badani KK, McKiernan JM. Synergism between metformin and statins in modifying the risk of biochemical recurrence following radical prostatectomy in men with diabetes. Prostate Cancer and Prostatic Diseases. 18: 63-8. PMID 25403419 DOI: 10.1038/pcan.2014.47 |
0.038 |
|
| 2006 |
Mitchell RE, Shah JB, Olsson CA, Benson MC, McKiernan JM. Does year of radical prostatectomy independently predict outcome in prostate cancer? Urology. 67: 368-72. PMID 16461087 DOI: 10.1016/j.urology.2005.08.036 |
0.038 |
|
| 2011 |
Ritch CR, Hruby G, Badani KK, Benson MC, McKiernan JM. Effect of statin use on biochemical outcome following radical prostatectomy. Bju International. 108: E211-6. PMID 21453350 DOI: 10.1111/j.1464-410X.2011.10159.x |
0.038 |
|
| 2001 |
Antman K, Benson MC, Chabot J, Cobrinik D, Grann VR, Jacobson JS, Joe AK, Katz AE, Kelly K, Neugut AI, Russo D, Tiersten A, Weinstein IB. Complementary and alternative medicine: the role of the cancer center. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 19: 55S-60S. PMID 11560974 |
0.038 |
|
| 1999 |
Hayek ORE, Noble CB, De La Taille A, Bagiella E, Benson MC. The necessity of a second prostate biopsy cannot be predicted by PSA or PSA derivatives (density or free:total ratio) in men with prior negative prostatic biopsies Current Opinion in Urology. 9: 371-375. PMID 10579073 DOI: 10.1097/00042307-199909000-00001 |
0.037 |
|
| 2005 |
Murphy AM, Gilbert SM, Katz AE, Goluboff ET, Sawczuk IS, Olsson CA, Benson MC, McKiernan JM. Re-evaluation of the tumour-node-metastasis staging of locally advanced renal cortical tumours: Absolute size (T2) is more significant than renal capsular invasion (T3a) Bju International. 95: 27-30. PMID 15638890 DOI: 10.1111/j.1464-410X.2005.05244.x |
0.037 |
|
| 1997 |
Ennis RD, Katz AE, De Vries GM, Heitjan DF, O'Toole KM, Rubin M, Buttyan R, Benson MC, Schiff PB. Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptase-polymerase chain reaction assay in patients with early stage prostate carcinoma: Independence from other pretreatment characteristics Cancer. 79: 2402-2408. PMID 9191530 DOI: 10.1002/(Sici)1097-0142(19970615)79:12<2402::Aid-Cncr16>3.0.Co;2-V |
0.037 |
|
| 2005 |
Chang SS, Benson MC, Campbell SC, Crook J, Dreicer R, Evans CP, Hall MC, Higano C, Kelly WK, Sartor O, Smith JA. Society of Urologic Oncology position statement: redefining the management of hormone-refractory prostate carcinoma. Cancer. 103: 11-21. PMID 15558815 DOI: 10.1002/cncr.20726 |
0.036 |
|
| 2000 |
De La Taille A, Benson MC, Bagiella E, Burchardt M, Shabsigh A, Olsson CA, Katz AE. Cryoablation for clinically localized prostate cancer using an argon-based system: Complication rates and biochemical recurrence Bju International. 85: 281-286. PMID 10671882 DOI: 10.1046/J.1464-410X.2000.00456.X |
0.036 |
|
| 2012 |
Motamedinia P, RiChard JL, McKiernan JM, DeCastro GJ, Benson MC. Role of immediate confirmatory prostate biopsy to ensure accurate eligibility for active surveillance. Urology. 80: 1070-4. PMID 23107398 DOI: 10.1016/j.urology.2012.07.049 |
0.036 |
|
| 2007 |
Gondi V, Deutsch I, Mansukhani M, O'Toole KM, Shah JN, Schiff PB, Katz AE, Benson MC, Goluboff ET, Ennis RD. Intermediate-risk localized prostate cancer in the PSA era: radiotherapeutic alternatives. Urology. 69: 541-6. PMID 17382161 DOI: 10.1016/j.urology.2006.12.015 |
0.035 |
|
| 2013 |
Spencer BA, Insel BJ, Hershman DL, Benson MC, Neugut AI. Racial disparities in the use of palliative therapy for ureteral obstruction among elderly patients with advanced prostate cancer. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 21: 1303-11. PMID 23292697 DOI: 10.1007/S00520-012-1666-6 |
0.035 |
|
| 2008 |
Mann MJ, DeCastro GJ, Desai M, Benson MC, McKiernan JM. Predictive significance of surgical margin status after prostatectomy for prostate cancer during PSA era. Urology. 72: 1203-7. PMID 18674807 DOI: 10.1016/j.urology.2008.04.068 |
0.035 |
|
| 2015 |
Berg WT, Danzig MR, Pak JS, Korets R, RoyChoudhury A, Hruby G, Benson MC, McKiernan JM, Badani KK. Delay from biopsy to radical prostatectomy influences the rate of adverse pathologic outcomes Prostate. 75: 1085-1091. PMID 25809289 DOI: 10.1002/Pros.22992 |
0.034 |
|
| 2022 |
Benson M, Dewey M, Friesner D. Pharmacist-led urine culture follow-ups in a rural emergency department. Journal of the American Pharmacists Association : Japha. PMID 36115759 DOI: 10.1016/j.japh.2022.08.019 |
0.034 |
|
| 2010 |
Barlow LJ, Badalato GM, Bashir T, Benson MC, McKiernan JM. The relationship between age at time of surgery and risk of biochemical failure after radical prostatectomy. Bju International. 105: 1646-9. PMID 19863523 DOI: 10.1111/j.1464-410X.2009.08977.x |
0.033 |
|
| 2007 |
Mitchell RE, Shah JB, Desai M, Mansukhani MM, Olsson CA, Benson MC, McKiernan JM. Changes in prognostic significance and predictive accuracy of Gleason grading system throughout PSA era: impact of grade migration in prostate cancer. Urology. 70: 706-10. PMID 17707892 DOI: 10.1016/j.urology.2007.06.1084 |
0.033 |
|
| 2007 |
Pierorazio PM, Kinnaman MD, Wosnitzer MS, Benson MC, McKiernan JM, Goluboff ET. Prostate volume and pathologic prostate cancer outcomes after radical prostatectomy. Urology. 70: 696-701. PMID 17991540 DOI: 10.1016/j.urology.2007.05.022 |
0.031 |
|
| 2009 |
Okhunov Z, Hruby GW, Mirabile G, Marruffo F, Lehman DS, Benson MC, Gupta M, Landman J. Prospective comparison of flexible fiberoptic and digital cystoscopes. Urology. 74: 427-30. PMID 19501889 DOI: 10.1016/j.urology.2009.01.007 |
0.031 |
|
| 2012 |
Badalato GM, Gaya JM, Hruby G, Patel T, Kates M, Sadeghi N, Benson MC, McKiernan JM. Immediate radical cystectomy vs conservative management for high grade cT1 bladder cancer: is there a survival difference? Bju International. 110: 1471-7. PMID 22487512 DOI: 10.1111/j.1464-410X.2012.11116.x |
0.031 |
|
| 2006 |
Petrylak DP, Ankerst DP, Jiang CS, Tangen CM, Hussain MH, Lara PN, Jones JA, Taplin ME, Burch PA, Kohli M, Benson MC, Small EJ, Raghavan D, Crawford ED. Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16. Journal of the National Cancer Institute. 98: 516-21. PMID 16622120 DOI: 10.1093/jnci/djj129 |
0.03 |
|
| 2007 |
Benson MC, McKiernan J. Prostate specific antigen screening. The Journal of Urology. 177: 1225-6. PMID 17382694 DOI: 10.1016/j.juro.2007.01.072 |
0.03 |
|
| 2000 |
Choi J, Shendrik I, Peacocke M, Peehl D, Buttyan R, Ikeguchi EF, Katz AE, Benson MC. Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia Urology. 56: 160-166. PMID 10869659 DOI: 10.1016/S0090-4295(00)00538-0 |
0.03 |
|
| 2012 |
RiChard JL, Motamedinia P, McKiernan JM, DeCastro GJ, Benson MC. Routine transition zone biopsy during active surveillance for prostate cancer rarely provides unique evidence of disease progression. The Journal of Urology. 188: 2177-80. PMID 23083872 DOI: 10.1016/j.juro.2012.08.011 |
0.03 |
|
| 2009 |
Phillips CK, Hruby GW, Mirabile G, Motamedinia P, Lehman DS, Okhunov Z, Singh H, Schwartz M, Benson MC, Landman J. Erythropoietin-induced optimization of renal function after warm ischemia. Journal of Endourology / Endourological Society. 23: 359-65. PMID 19309300 DOI: 10.1089/end.2008.0183 |
0.03 |
|
| 1999 |
Lee N, Newhouse JH, Olsson CA, Benson MC, Petrylak DP, Schiff PB, Bagiella E, Malyszko B, Ennis RD. Which patients with newly diagnosed prostate cancer need a computed tomography scan of the abdomen and pelvis? An analysis based on 588 patients Urology. 54: 490-494. PMID 10475360 DOI: 10.1016/S0090-4295(99)00150-8 |
0.029 |
|
| 2014 |
Lin J, Deibert CM, Holder D, Benson MC, McKiernan JM. The role of pelvic lymphadenectomy in non-muscle invasive bladder cancer. The Canadian Journal of Urology. 21: 7108-13. PMID 24529010 |
0.029 |
|
| 2015 |
Gaya JM, López-Martínez JM, Karni-Schmidt O, Bonal DM, Algaba F, Palou J, Villavicencio H, Benson MC, Cordon-Cardo C, Castillo-Martin M. ΔNp63 expression is a protective factor of progression in clinical high grade T1 bladder cancer. The Journal of Urology. 193: 1144-50. PMID 25444981 DOI: 10.1016/J.Juro.2014.10.098 |
0.029 |
|
| 2012 |
Yeshchina O, Badalato GM, Wosnitzer MS, Hruby G, RoyChoudhury A, Benson MC, Petrylak DP, McKiernan JM. Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder. Urology. 79: 384-90. PMID 22196406 DOI: 10.1016/J.Urology.2011.10.050 |
0.029 |
|
| 2012 |
Shen J, Hruby GW, McKiernan JM, Gurvich I, Lipsky MJ, Benson MC, Santella RM. Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer. The Prostate. 72: 1469-77. PMID 22298119 DOI: 10.1002/pros.22499 |
0.028 |
|
| 2008 |
Laudano MA, Klafter FE, Katz M, McCann TR, Desai M, Benson MC, McKiernan JM. Pathological tumour diameter predicts risk of conventional subtype in small renal cortical tumours. Bju International. 102: 1385-8. PMID 18710458 DOI: 10.1111/j.1464-410X.2008.07876.x |
0.028 |
|
| 2012 |
Delgado-Cruzata L, Hruby GW, Gonzalez K, McKiernan J, Benson MC, Santella RM, Shen J. DNA methylation changes correlate with Gleason score and tumor stage in prostate cancer. Dna and Cell Biology. 31: 187-92. PMID 21830905 DOI: 10.1089/Dna.2011.1311 |
0.027 |
|
| 2014 |
Spencer BA, Shim JJ, Hershman DL, Zacharia BE, Lim EA, Benson MC, Neugut AI. Metastatic epidural spinal cord compression among elderly patients with advanced prostate cancer. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 22: 1549-55. PMID 24429841 DOI: 10.1007/S00520-013-2112-0 |
0.027 |
|
| 2008 |
Motamedinia P, Korets R, Spencer BA, Benson MC, McKiernan JM. Body mass index trends and role of obesity in predicting outcome after radical prostatectomy. Urology. 72: 1106-10. PMID 18602142 DOI: 10.1016/j.urology.2008.04.021 |
0.027 |
|
| 2016 |
Deibert CM, Silva MV, RoyChowdry A, McKiernan JM, Scherr DS, Seres D, Benson MC. A Prospective Randomized Trial of the Effects of Early Enteral Feeding after Radical Cystectomy. Urology. PMID 27402372 DOI: 10.1016/J.Urology.2016.06.045 |
0.026 |
|
| 2015 |
Wahnoun R, Benson M, Helms-Tillery S, Adelson PD. Delineation of somatosensory finger areas using vibrotactile stimulation, an ECoG study. Brain and Behavior. 5: e00369. PMID 26516605 DOI: 10.1002/brb3.369 |
0.025 |
|
| 2008 |
Schmitz-Dräger BJ, Hartmann A, Hüsgens G, Groskopf J, Gleissner J, Blana A, Berges R, Blasé A, Rittenhouse H, Hessels D, Schalken J, Benson MC. UIJ - Prostate cancer diagnosis in high risk patients: The Finasteride challenge trial Urotoday International Journal. 1. DOI: 10.3834/uij.1939.4810.2008.09.13 |
0.024 |
|
| 2009 |
Lee DJ, Rothberg MB, McKiernan JM, Benson MC, Badani KK. Robot-assisted radical cystoprostatectomy in complex surgical patients: single institution report. The Canadian Journal of Urology. 16: 4664-9. PMID 19497175 |
0.024 |
|
| 2015 |
Whalen MJ, RiChard JL, Ghandour R, Lipsky M, Piecuch M, Benson MC, Nieder AM, DeCastro GJ, McKiernan JM. Lessons learned from routine intraoperative ureteral margin frozen sections during radical cystectomy Urology Practice. 2: 90-95. DOI: 10.1016/j.urpr.2014.12.001 |
0.024 |
|
| 2004 |
Goetzl MA, Goluboff ET, Murphy AM, Katz AE, Mansukhani M, Sawczuk IS, Olsson CA, Benson MC, McKiernan JM. A contemporary evaluation of cytoreductive nephrectomy with tumor thrombus: Morbidity and long-term survival Urologic Oncology: Seminars and Original Investigations. 22: 182-187. PMID 15271312 DOI: 10.1016/j.urolonc.2004.02.001 |
0.024 |
|
| 2012 |
Wosnitzer MS, Hruby GW, Murphy AM, Barlow LJ, Cordon-Cardo C, Mansukhani M, Petrylak DP, Benson MC, McKiernan JM. A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer. Cancer. 118: 358-64. PMID 21717438 DOI: 10.1002/cncr.26278 |
0.024 |
|
| 2011 |
Ritch CR, Kearns JT, Mues AC, Hruby GW, Benson MC, McKiernan JM, Landman J. Comparison of distal ureteral management strategies during laparoscopic nephroureterectomy. Journal of Endourology / Endourological Society. 25: 1149-54. PMID 21689004 DOI: 10.1089/end.2010.0542 |
0.024 |
|
| 2005 |
Mitchell RE, Katz MH, McKiernan JM, Benson MC. The evaluation and staging of clinically localized prostate cancer. Nature Clinical Practice. Urology. 2: 356-7. PMID 16474713 DOI: 10.1038/ncpuro0260 |
0.024 |
|
| 2009 |
Laudano MA, Lambert SM, Masson P, McCann TR, Desai M, Benson MC, McKiernan JM. How often do available preoperative risk factors accurately predict the risk assessed after surgery for localized prostate cancer? Bju International. 103: 317-20. PMID 18778341 DOI: 10.1111/j.1464-410X.2008.08031.x |
0.023 |
|
| 2013 |
Irshad S, Bansal M, Castillo-Martin M, Zheng T, Aytes A, Wenske S, Le Magnen C, Guarnieri P, Sumazin P, Benson MC, Shen MM, Califano A, Abate-Shen C. A molecular signature predictive of indolent prostate cancer (Science Translational Medicine (2013) 5, (203er9)) Science Translational Medicine. 5. DOI: 10.1126/scitranslmed.3007585 |
0.023 |
|
| 1998 |
Sarosdy MF, Manyak MJ, Sagalowsky AI, Belldegrun A, Benson MC, Bihrle W, Carroll PR, Ellis WJ, Hudson MA, Sharkey FE. Oral bropirimine immunotherapy of bladder carcinoma in situ after prior intravesical bacille Calmette-Guerin Urology. 51: 226-231. PMID 9495702 DOI: 10.1016/S0090-4295(97)00510-4 |
0.023 |
|
| 2011 |
Lee DJ, Ritch C, Desai M, Benson MC, McKiernan JM. The interaction of body mass index and race in predicting biochemical failure after radical prostatectomy. Bju International. 107: 1741-7. PMID 20942835 DOI: 10.1111/j.1464-410X.2010.09768.x |
0.022 |
|
| 2005 |
Sarosdy MF, Tangen CM, Weiss GR, Nestok BR, Benson MC, Schellhammer PF, Sagalowsky AI, Wood DP, Crawford ED. A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guérin for carcinoma in situ of the bladder: a Southwest Oncology Group Study. Urologic Oncology. 23: 386-9. PMID 16301114 DOI: 10.1016/j.urolonc.2005.05.028 |
0.022 |
|
| 2012 |
Korets R, Seager CM, Pitman MS, Hruby GW, Benson MC, McKiernan JM. Effect of delaying surgery on radical prostatectomy outcomes: a contemporary analysis. Bju International. 110: 211-6. PMID 22093486 DOI: 10.1111/j.1464-410X.2011.10666.x |
0.021 |
|
| 2011 |
Lee DJ, Hruby G, Benson MC, McKiernan JM. Renal function and oncologic outcomes in nephron sparing surgery for renal masses in solitary kidneys. World Journal of Urology. 29: 343-8. PMID 20623290 DOI: 10.1007/s00345-010-0576-9 |
0.02 |
|
| 2008 |
Joel Decastro G, Benson MC, Badani KK. Robot-assisted radical cystoprostatectomy in the post-radiation and chemotherapy patient Journal of Robotic Surgery. 2: 269-271. DOI: 10.1007/s11701-008-0120-8 |
0.02 |
|
| 2001 |
Nejat RJ, Purohit R, Goluboff ET, Petrylak D, Rubin MA, Benson MC. Cure of undifferentiated small cell carcinoma of the urinary bladder with M-VAC chemotherapy Urologic Oncology. 6: 53-55. DOI: 10.1016/S1078-1439(00)00098-3 |
0.02 |
|
| 2014 |
Benson M, Kathman JD. United nations bias and force commitments in civil conflicts Journal of Politics. 76: 350-363. DOI: 10.1017/S0022381613001497 |
0.019 |
|
| 2014 |
Woldu SL, Weinberg AC, Korets R, Ghandour R, Danzig MR, RoyChoudhury A, Kalloo SD, Benson MC, DeCastro GJ, McKiernan JM. Who really benefits from nephron-sparing surgery? Urology. 84: 860-7. PMID 25260447 DOI: 10.1016/J.Urology.2014.05.061 |
0.019 |
|
| 1996 |
Whang M, O'Toole K, Bixon R, Brunetti J, Ikeguchi E, Olsson CA, Sawczuk TS, Benson MC. Incidence des cancers du rein multifocaux chez les patients candidats àune chirurgie partielle Progres En Urologie. 6: 163. |
0.019 |
|
| 2007 |
Lambert EH, Pierorazio PM, Shabsigh A, Olsson CA, Benson MC, McKiernan JM. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus. Urology. 69: 1054-8. PMID 17572185 DOI: 10.1016/j.urology.2007.02.052 |
0.018 |
|
| 2012 |
Berg WT, Rich CR, Badalato GM, Deibert CM, Wambi CO, Landman J, Benson MC, Badani KK. The first assistant sparing technique robot-assisted partial nephrectomy decreases warm ischemia time while maintaining good perioperative outcomes. Journal of Endourology / Endourological Society. 26: 1448-53. PMID 22691152 DOI: 10.1089/end.2012.0129 |
0.018 |
|
| 2006 |
Mitchell RE, Gilbert SM, Murphy AM, Olsson CA, Benson MC, McKiernan JM. Partial nephrectomy and radical nephrectomy offer similar cancer outcomes in renal cortical tumors 4 cm or larger. Urology. 67: 260-4. PMID 16461075 DOI: 10.1016/j.urology.2005.08.057 |
0.017 |
|
| 2003 |
Stas SN, Anastasiadis AG, Fisch H, Benson MC, Shabsigh R. Urologic aspects of andropause Urology. 61: 261-266. PMID 12597927 DOI: 10.1016/S0090-4295(02)02242-2 |
0.017 |
|
| 2001 |
Fromer DL, Bacon CG, Birkhoff JD, Giovannucci E, Hardy MA, Testa M, Benvenisty AI, Kawachi I, Bennett B, Benson MC. Bilateral intrarenal adrenal glands in cadaveric donor kidneys resembling renal cell carcinoma on intraoperative frozen section Journal of Urology. 166: 1820-1821. PMID 11586232 |
0.016 |
|
| 2009 |
Fahl KN, Poon SA, Badani KK, Benson MC. Paraneoplastic production of heparin-like anticoagulant in a patient with metastatic transitional cell carcinoma. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 3: E61-3. PMID 19829722 |
0.016 |
|
| 2010 |
Murphy AM, Berkman DS, Desai M, Benson MC, McKiernan JM, Badani KK. The number of negative pelvic lymph nodes removed does not affect the risk of biochemical failure after radical prostatectomy. Bju International. 105: 176-9. PMID 19549117 DOI: 10.1111/j.1464-410X.2009.08707.x |
0.015 |
|
| 2011 |
Haramis G, Mues AC, Rosales JC, Okhunov Z, Lanzac AP, Badani K, Gupta M, Benson MC, McKiernan J, Landman J. Natural history of renal cortical neoplasms during active surveillance with follow-up longer than 5 years. Urology. 77: 787-91. PMID 21167561 DOI: 10.1016/j.urology.2010.09.031 |
0.015 |
|
| 2003 |
Gilbert SM, Russo P, Benson MC, Olsson CA, McKiernan JM. The evolving role of partial nephrectomy in the management of renal cell carcinoma Current Oncology Reports. 5: 239-244. PMID 12667422 DOI: 10.1007/S11912-003-0116-5 |
0.015 |
|
| 2009 |
Barlow LJ, McKiernan JM, Benson MC. The novel use of intravesical docetaxel for the treatment of non-muscle invasive bladder cancer refractory to BCG therapy: a single institution experience. World Journal of Urology. 27: 331-5. PMID 19214528 DOI: 10.1007/s00345-009-0377-1 |
0.015 |
|
| 2015 |
Schubert T, Danzig MR, Kotamarti S, Ghandour RA, Lascano D, Dubow BP, Decastro GJ, Benson MC, McKiernan JM. Mixed low- and high-grade non-muscle-invasive bladder cancer: a histological subtype with favorable outcome. World Journal of Urology. 33: 847-52. PMID 25149472 DOI: 10.1007/s00345-014-1383-5 |
0.014 |
|
| 2002 |
Fromer DL, Shabsigh A, Benson MC, Gupta M. Simultaneous multiple double pigtail stents for malignant ureteral obstruction Urology. 59: 594-596. PMID 11927324 DOI: 10.1016/S0090-4295(01)01646-6 |
0.014 |
|
| 2015 |
Lascano D, Pak JS, Kates M, Finkelstein JB, Silva M, Hagen E, RoyChoudhury A, Bivalacqua TJ, DeCastro GJ, Benson MC, McKiernan JM. Validation of a frailty index in patients undergoing curative surgery for urologic malignancy and comparison with other risk stratification tools Urologic Oncology: Seminars and Original Investigations. DOI: 10.1016/j.urolonc.2015.06.002 |
0.014 |
|
| 2015 |
Perez TY, Danzig MR, Ghandour RA, Badani KK, Benson MC, McKiernan JM. Impact of the 2012 United States Preventive Services Task Force statement on prostate-specific antigen screening: analysis of urologic and primary care practices. Urology. 85: 85-9. PMID 25440819 DOI: 10.1016/j.urology.2014.07.072 |
0.013 |
|
| 2013 |
Spencer BA, McBride RB, Hershman DL, Buono D, Herr HW, Benson MC, Gupta-Mohile S, Neugut AI. Adjuvant intravesical bacillus calmette-guérin therapy and survival among elderly patients with non-muscle-invasive bladder cancer. Journal of Oncology Practice / American Society of Clinical Oncology. 9: 92-8. PMID 23814517 DOI: 10.1200/Jop.2011.000480 |
0.013 |
|
| 2000 |
Gomella LG, Albertsen PC, Benson MC, Forman JD, Soloway MS. The use of video-based patient education for shared decision-making in the treatment of prostate cancer Seminars in Urologic Oncology. 18: 182-187. PMID 10975489 |
0.012 |
|
| 2013 |
Barlow LJ, Benson MC. Experience with newer intravesical chemotherapy for high-risk non-muscle-invasive bladder cancer. Current Urology Reports. 14: 65-70. PMID 23378162 DOI: 10.1007/s11934-013-0312-2 |
0.012 |
|
| 2009 |
Poon SA, Gonzalez JR, Benson MC, McKiernan JM. Invasion of renal sinus fat is not an independent predictor of survival in pT3a renal cell carcinoma. Bju International. 103: 1622-5. PMID 19154464 DOI: 10.1111/j.1464-410X.2008.08239.x |
0.012 |
|
| 2013 |
Barlow LJ, McKiernan JM, Benson MC. Long-term survival outcomes with intravesical docetaxel for recurrent nonmuscle invasive bladder cancer after previous bacillus Calmette-Guérin therapy. The Journal of Urology. 189: 834-9. PMID 23123371 DOI: 10.1016/j.juro.2012.10.068 |
0.01 |
|
| 2006 |
Gilbert SM, Whitson JM, Mansukhani M, Buttyan R, Benson MC, Olsson CA, Sawczuk IS, McKiernan JM. Detection of carbonic anhydrase-9 gene expression in peripheral blood cells predicts risk of disease recurrence in patients with renal cortical tumors. Urology. 67: 942-5. PMID 16698354 DOI: 10.1016/j.urology.2005.11.034 |
0.01 |
|
| 2007 |
Samadi D, Levinson A, Hakimi A, Shabsigh R, Benson MC. From proficiency to expert, when does the learning curve for robotic-assisted prostatectomies plateau? The Columbia University experience. World Journal of Urology. 25: 105-10. PMID 17192816 DOI: 10.1007/s00345-006-0137-4 |
0.01 |
|
| 2016 |
Benson MC. Editorial Comment. Urology. 90: 147. PMID 27036684 DOI: 10.1016/j.urology.2015.11.065 |
0.01 |
|
| 2015 |
Meyer A, Woldu SL, Weinberg AC, Thoreson GR, Pierorazio P, Matulay JT, Benson MC, DeCastro GJ, McKiernan JM. Predicting Renal Parenchymal Loss after Nephron Sparing Surgery. The Journal of Urology. PMID 25818030 DOI: 10.1016/j.juro.2015.03.098 |
0.01 |
|
| 2015 |
Danzig MR, Berg AR, Ghandour RA, Lascano D, Whalen MJ, Benson MC, DeCastro GJ, McKiernan JM. Partial Cystectomy for Primary Bladder Tumors in Contemporary Patients with Diverse Tumor Locations Urology Practice. DOI: 10.1016/j.urpr.2015.02.005 |
0.01 |
|
| 2014 |
Stevenson SM, Danzig MR, Ghandour RA, Deibert CM, Decastro GJ, Benson MC, McKiernan JM. Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer. Urologic Oncology. 32: 1172-7. PMID 24998787 DOI: 10.1016/j.urolonc.2014.05.001 |
0.01 |
|
| 2014 |
Benson MC. Exploring extension involvement in farm to school program activities Journal of Extension. 52. |
0.01 |
|
| 2013 |
Benson MC. Postcoloniality and Privilege in New Lifestyle Flows: The Case of North Americans in Panama Mobilities. 8: 313-330. DOI: 10.1080/17450101.2013.810403 |
0.01 |
|
| 2011 |
Wosnitzer MS, Domingo-Domenech J, Castillo-Martin M, Ritch C, Mansukhani M, Petrylack DP, Benson MC, McKiernan JM, Cordon-Cardo C. Predictive value of microtubule associated proteins tau and stathmin in patients with nonmuscle invasive bladder cancer receiving adjuvant intravesical taxane therapy. The Journal of Urology. 186: 2094-100. PMID 21944130 DOI: 10.1016/J.Juro.2011.06.051 |
0.01 |
|
| 2011 |
Patel T, Kirby W, Hruby G, Benson MC, McKiernan JM, Badani K. Heparin prophylaxis and the risk of venous thromboembolism after robotic-assisted laparoscopic prostatectomy. Bju International. 108: 729-32. PMID 21231988 DOI: 10.1111/j.1464-410X.2010.09910.x |
0.01 |
|
| 2010 |
Mues AC, Palacios JM, Haramis G, Casazza C, Badani K, Gupta M, McKiernan J, Benson MC, Landman J. Contemporary experience in the management of angiomyolipoma. Journal of Endourology / Endourological Society. 24: 1883-6. PMID 20919915 DOI: 10.1089/end.2010.0223 |
0.01 |
|
| 2010 |
Mues AC, Haramis G, Badani K, Gupta M, Benson MC, McKiernan JM, Landman J. Active surveillance for larger (cT1bN0M0 and cT2N0M0) renal cortical neoplasms. Urology. 76: 620-3. PMID 20599256 DOI: 10.1016/j.urology.2010.04.021 |
0.01 |
|
| 2010 |
Benson MC. Editorial comment. The Journal of Urology. 184: 91. PMID 20478595 DOI: 10.1016/j.juro.2010.03.158 |
0.01 |
|
| 2010 |
Benson MC. Editorial comment. The Journal of Urology. 183: 2170. PMID 20399469 DOI: 10.1016/j.juro.2010.02.2426 |
0.01 |
|
| 2010 |
Rosales JC, Haramis G, Moreno J, Badani K, Benson MC, McKiernan J, Casazza C, Landman J. Active surveillance for renal cortical neoplasms. The Journal of Urology. 183: 1698-702. PMID 20299038 DOI: 10.1016/j.juro.2010.01.024 |
0.01 |
|
| 2010 |
Woldu SL, Barlow LJ, Patel T, Hruby GW, Benson MC, McKiernan JM. Single institutional experience with nephron-sparing surgery for pathologic stage T3bNxM0 renal cell carcinoma confined to the renal vein. Urology. 76: 639-42. PMID 20163841 DOI: 10.1016/j.urology.2009.10.073 |
0.01 |
|
| 2010 |
Barlow LJ, Seager CM, Benson MC, McKiernan JM. Novel intravesical therapies for non-muscle-invasive bladder cancer refractory to BCG. Urologic Oncology. 28: 108-11. PMID 20123359 DOI: 10.1016/j.urolonc.2009.03.029 |
0.01 |
|
| 2010 |
Barlow LJ, Mann MJ, Badani KK, Benson MC, McKiernan JM. Has the advent of minimally invasive surgery altered the risk profile of patients undergoing prostatectomy? Urology. 75: 427-30. PMID 19942262 DOI: 10.1016/j.urology.2009.07.1352 |
0.01 |
|
| 2010 |
Laudano MA, Barlow LJ, Murphy AM, Petrylak DP, Desai M, Benson MC, McKiernan JM. Long-term clinical outcomes of a phase I trial of intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to standard intravesical therapy. Urology. 75: 134-7. PMID 19913890 DOI: 10.1016/j.urology.2009.06.112 |
0.01 |
|
| 2010 |
Benson MC. Editorial comment. The Journal of Urology. 183: 131. PMID 19913248 DOI: 10.1016/j.juro.2009.08.203 |
0.01 |
|
| 2010 |
Benson MC. The context and trajectory of lifestyle migration: The case of the British residents of Southwest France European Societies. 12: 45-64. DOI: 10.1080/14616690802592605 |
0.01 |
|
| 2009 |
Murphy AM, Buck AM, Benson MC, McKiernan JM. Increasing detection rate of benign renal tumors: evaluation of factors predicting for benign tumor histologic features during past two decades. Urology. 73: 1293-7. PMID 19371933 DOI: 10.1016/j.urology.2008.12.072 |
0.01 |
|
| 2008 |
Lehman DS, Hruby GW, Phillips CK, McKiernan JM, Benson MC, Landman J. First Prize (tie): Laparoscopic renal cryoablation: efficacy and complications for larger renal masses. Journal of Endourology / Endourological Society. 22: 1123-7. PMID 18484888 DOI: 10.1089/end.2008.0077 |
0.01 |
|
| 2008 |
Benson MC, Mckiernan JM. UIJ - Long term clinical outcome of a phase i trial of intravesical docetaxel in the management of superficial bladder cancer refractory to standard intravesical therapy Urotoday International Journal. 1. DOI: 10.3834/uij.1939.4810.2008.09.06 |
0.01 |
|
| 2007 |
Pierorazio PM, McKiernan JM, McCann TR, Mohile S, Petrylak D, Benson MC. Outcome after cytoreductive nephrectomy for metastatic renal cell carcinoma is predicted by fractional percentage of tumour volume removed. Bju International. 100: 755-9. PMID 17822456 DOI: 10.1111/j.1464-410X.2007.07108.x |
0.01 |
|
| 2007 |
Lambert EH, Pierorazio PM, Olsson CA, Benson MC, McKiernan JM, Poon S. The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy. Bju International. 100: 33-6. PMID 17552951 DOI: 10.1111/j.1464-410X.2007.06912.x |
0.01 |
|
| 2007 |
Pierorazio PM, Murphy AM, Benson MC, McKiernan JM. Gender discrepancies in the diagnosis of renal cortical tumors. World Journal of Urology. 25: 81-5. PMID 17066264 DOI: 10.1007/s00345-006-0124-9 |
0.01 |
|
| 2006 |
Gilbert SM, Murphy AM, Katz AE, Goluboff ET, Sawczuk IS, Olsson CA, Benson MC, McKiernan JM. Reevaluation of TNM staging of renal cortical tumors: recurrence and survival for T1N0M0 and T3aN0M0 tumors are equivalent. Urology. 68: 287-91. PMID 16904438 DOI: 10.1016/j.urology.2006.02.012 |
0.01 |
|
| 2006 |
McKiernan JM, Masson P, Murphy AM, Goetzl M, Olsson CA, Petrylak DP, Desai M, Benson MC. Phase I trial of intravesical docetaxel in the management of superficial bladder cancer refractory to standard intravesical therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 3075-80. PMID 16809732 DOI: 10.1200/JCO.2005.03.1161 |
0.01 |
|
| 2004 |
Gilbert SM, Decastro GJ, Benson MC. Large multilocular Müllerian duct cyst presenting as pelvic mass Urology. 64: 375. PMID 15302500 DOI: 10.1016/j.urology.2004.04.039 |
0.01 |
|
| 2001 |
Fromer DL, Birkhoff JD, Hardy MA, Benvenisty AI, Bennett B, Benson MC. Radio frequency ablation of lung metastases from renal cell carcinoma Journal of Urology. 166: 1827-1828. PMID 11586236 |
0.01 |
|
| 1999 |
Benson MC. Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder Annals of Oncology. 10: 1269-1270. PMID 10631452 DOI: 10.1023/A:1008370506121 |
0.01 |
|
| Hide low-probability matches. |